InternationalUSRemember you can easily switch between MIP US and MIP International at any time

MIP European Patent Reform Forum 2016 - Paris agenda

September 6, Munich; September 8, Paris




Agenda-Munich

Agenda- Paris

Speakers - Munich

Speakers - Paris

delegates Munich

Delegates - Paris



Contact us

Download the brochure


08:15 Registration

08:50 Opening remarks by James Nurton, 
managing editor, Managing IP

09:00 Patent implications of Brexit

  • Understanding Brexit consequences on the UPC
  • Examining the future of the UPC: with or without the UK?
  • Will the Unitary Patent still be a priority for industry?
  • Policy consequences of Brexit

Stanislas Roux-Vaillard, partner, Hogan Lovells (moderator)
Margot Fröhlinger, principal director, patent law and multilateral affairs, European Patent Office
Sonia Cooper, senior patent attorney, IP Policy and Strategy, Microsoft
Laura Whiting,
senior associate, Hogan Lovells


09:45 Litigation and enforcement strategies in view of the current framework

  • Recent litigation tools and trends
  • Comparison of litigation in different jurisdictions: Germany versus France versus UK
  • Analysing the procedural advantages of each jurisdiction

Joachim Feldges, partner, Allen & Overy (moderator)
Robert Fitt, senior patent litigation counsel, Mylan
David Por, partner, Allen & Overy


10:30 Coffee break and networking


10:50 FOCUS: IT & TMT sectors

  • The permanent opt-out: what would the UPC look like without UK involvement for telecoms, networking, IoT and other CII patents?  NPE heaven?
  • Patent prosecution: cost benefit analysis of the UP excluding UK coverage
  • EPO oppositions: (even) more attractive in a fragmented Europe?
  • Hi-tech rarely respects borders: would the UK courts wither or flourish in the shadow of the UPC?

Graham Burnett-Hall, partner, Marks & Clerk (moderator)
Adrien Renoult, IP corporate counsel, Nokia
Pete Wilson, senior patent attorney, BT
Thomas Prock, partner, Marks & Clerk


11:35 Frand: Litigating and licensing SEPs in Europe

  • How Huawei v ZTE is being applied before the national courts in Europe
  • How the framework might be applied before the UPC
  • Use of UPC rules/procedures for SEP cases
  • UPC jurisdiction to determine Frand disputes
  • What happens to SEP litigation if the UPC is delayed, never opens for business or proceeds without the UK?

Alexandra Brodie, partner, Gowling WLG (moderator)
Olivier Thirard, deputy legal director, intellectual property, Orange
Clemens Heusch,
head of European IP litigation, Nokia


12:20 Effective patent dispute resolution - What makes a successful strategy?

  • Avoiding the dispute in the first place
  • Factors for choosing the right venue(s)
  • Is there an ideal jurisdiction?
  • Managing outside counsel

Peter Damerell, partner, Powell Gilbert (moderator)
Alessandra Cincotti
, senior legal counsel, Inserm Transfert
Maximin Gourcy
, intellectual property manager, DS Smith
David Lancaster, senior associate, Powell Gilbert


13:05 Lunch and networking


14:00 FOCUS: Life sciences and pharma

  • Would UPC minus the UK be attractive to the pharma industry?
  • If the UPC proceeds without the UK, what will be the role of the UK on the global patent litigation stage?
  • Post-grant validity challenges: EPO oppositions versus a fragmented litigation system
  • SPCs post Brexit

Dominic Adair, partner, Bristows (moderator)
Charlotte Retzler, senior vice president, intellectual property, Ipsen Pharma
Gavin Lawson, senior manager, intellectual property, Gilead Sciences
Mark Chadwick, senior patent attorney, DSM
Greg Bacon, senior associate, Bristows


14:45 Drawing comparisons between the USA and Europe

  • Identifying the implications of the current system on US filing in Europe
  • What can be learned from PTAB proceedings?
  • Opposition proceedings in Europe versus US system
  • Case study: recent US Supreme Court decisions

Anita Varma, partner, Ropes & Gray (moderator)
Bruce Elder, director, intellectual property and licensing, Integrated Device Technology
Edward Kelly
, partner, Ropes & Gray


15:30 Coffee break and networking


15:50 Obtaining evidence of an infringement in Europe

  • Overview of different European approaches to obtaining evidence
  • Obtaining evidence of an infringement – saisie-contrefaçon
  • Actions for declaration of non-infringement
  • How will evidence be used in the UPC: will you be able to use a combination of systems?

Caroline Casalonga, partner, Casalonga (moderator)
Judge Sam Granata, Antwerp Commercial Court
Axel Casalonga,
senior partner, Casalonga


16:35 Patent enforcement: Alternatives to court proceedings

  • Suitable cases for arbitration and mediation
  • Relevant types of arbitration and mediation (WIPO, ITC, investment treaties, UPC)
  • Enforcement of arbitration judgements
  • Trade secrets: impact of the new EU Directive on national court proceedings/attractiveness of arbitration

Pauline Debré, partner, Linklaters (moderator)
Ben Ostapuk, head of patent litigation, Intel
Julia Schönbohm, partner, Linklaters
Yohan Liyanage,
counsel, Linklaters


17:20 Close of conference

 


 

Sponsors


Bristows
Casalonga

Gowling WLG
Hogan Lovells
Linklaters

Marks & Clerk
Powell Gilbert
Ropes & Gray











Exhibitor

Valipat







 

Association partner

AIPPI


profile

Managing IP

ManagingIP

ManagingIP profile

Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg

Dec 15 2017 10:12 ·  reply ·  retweet ·  favourite
ManagingIP profile

Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32

Dec 14 2017 09:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co

Dec 12 2017 10:22 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

End of Year 2017

Tribal sovereign immunity: Taking a wrecking ball to the IPR system

The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?



Most read articles

Supplements